Human erythroid models of sickle cell disease
Deborah E. Daniels, Maria A. Lizarralde‐Iragorri, Fatima O. Oyawoye, David C. Rees, Jan Frayne, Sara El Hoss · 2026
Read Human erythroid models of sickle cell disease by Deborah E. Daniels, Maria A. Lizarralde‐Iragorri, Fatima O. Oyawoye, David C. Rees, Jan Frayne, Sara El Hoss (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13671357.txt.
Description
Deborah Daniels and co-authors review lab models of sickle cell disease in a paper from 2026. The disease is a set of inherited red blood cell disorders that burden health systems worldwide. Gene therapy and stem cell transplants have advanced, yet treatment choices stay limited.
New drugs must be found, and human cell models are a key tool. The review covers red cells taken from patients and stem cells from blood. It also covers lab-made stem cells and immortal cell lines that grow forever. Each model has strengths and limits for drug screening. Mixed cultures and organoids may add realism. The survey helps labs pick the right model for each question.
Catalog record
| CREATOR | Deborah E. Daniels, Maria A. Lizarralde‐Iragorri, Fatima O. Oyawoye, David C. Rees, Jan Frayne, Sara El Hoss |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 42 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |